Scope.

This subpart sets forth the requirements relating to the following: (a) Drug utilization management programs, quality assurance measures and systems, and MTM programs for Part D sponsors. (b) Appropriate dispensing of prescription drugs in long-term care facilities under PDPs and MA-PD plans. (c) Consumer satisfaction surveys of Part D plans. (d) Electronic prescription drug programs for prescribers, dispensers, and Part D sponsors. (e) Quality improvement organization (QIO) activities. (f) Compliance deemed on the basis of accreditation. (g) Accreditation organizations. (h) Procedures for the approval of accreditation organizations as a basis for deeming compliance. [70 FR 4525, Jan. 28, 2005, as amended at 70 FR 67593, Nov. 7, 2005; 76 FR 21573, Apr. 15, 2011; 89 FR 30834, Apr. 23, 2024]